SAFETY AND EFFICACY OF THE COMBO BIO-ENGINEERED STENT IN PATIENTS AT HIGH BLEEDING RISK: RESULTS FROM THE MASCOT POST-MARKETING REGISTRY

The Combo stent is a drug eluting stent with abluminal sirolimus in a bioabsorbable polymer and luminal anti-CD34 for endothelial progenitor capture and rapid endothelialization. This property may permit shorter period of dual antiplatelet therapy (DAPT) in patients at high bleeding risk (HBR). We